SP07 | EFFICACY AND TOLERABILITY OF THE IBRUTINIB-VENETOCLAX COMBINATION IN THE TREATMENT OF ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA: A MONOCENTRIC CLINICAL EXPERIENCE
Introduction: CLL is a heterogeneous B-cell malignancy with a range of clinical and molecular features. aCLL represents an unmet clinical need because it is characterized by unconventional features (e.g. lack of CD23 expression, evidence of BCL1 rearrangement) with a poor response to classical trea...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Ferrata Storti Foundation
2025-09-01
|
| Цуврал: | Haematologica |
| Онлайн хандалт: | https://haematologica.org/article/view/12327 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
